npj VaccinesImmunologyPeer-reviewed journal article
Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant.
Farha NaziD, Nicholas Hagspiel, Feifan Xu, Brandon A. ThompsoniD, G. Brett MoreauiD, Mary Young, Joel F. Herbein, Christopher B. FoxiD, William A. PetriiD, Mayuresh M. Abhyankar
Abstract
We report a comprehensive evaluation of the toxin B (TcdB) vaccine adjuvanted with a dual Toll-like receptor ligand liposome adjuvant for Clostridioides difficile infection (CDI). The vaccine completely protected mice from a lethal infection. Compared to alum adjuvanted TcdB, it generated functionally superior systemic antibodies and supported strong memory B cell and gut IgA responses. This pharmaceutically acceptable adjuvant platform holds promise for developing a next-generation CDI vaccine.
- Citations
- 7
- FWCI
- 4.67
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Receptor-binding domain 2 of Clostridioides difficile binary toxin as a promising vaccine component against C. difficile infection
Shaohui Wang, Joshua Heuler, … Xingmin Sun·bioRxiv·Aug 31, 2026
- Clostridioides difficile toxin A and toxin B inhibit toxin-specific adaptive immune responses through glucosyltransferase-dependent activity
Jeffrey R. Maslanka, Jennifer Londregan, … Michael C. Abt·Mucosal ImmunologyPeer-reviewed·Aug 18, 2025
- Subunit Vaccine-Elicited Effector-Like Memory CD8 T cells Protect Against Listeriosis
- Nasal immunization with the C-terminal domain of BclA3 induced specific IgG production and attenuated disease symptoms in mice infected with Clostridioides difficile spores
A. R. Conduto Dias Maia, R. Reyes-Ramírez, … D. Paredes-Sabja·bioRxiv·May 31, 2020
- A TLR4 ligand-based adjuvant for promoting the immunogenicity of Typhoid subunit vaccines
K. R. Alugupalli·bioRxiv·Mar 22, 2024
- Generation and characterization of a novel MHC-II tetramer for tracking and characterization of toxin B-specific CD4+ T cell responses
Jeffrey R. Maslanka, Qianxuan She, … Michael C. Abt·The Journal of ImmunologyPeer-reviewed·Aug 1, 2026